“I had a call from Daryl from 3M [Daryl Jones, a senior legal adviser at the 3M subsidiary which used to employ him] the 2 days after you called me. I told them I had been asked for a witness statement from yourselves and planned to be in London on Tuesday 8th December to provide a witness statement. They informed me that I was bound by a confidentiality agreement and could not provide a witness statement on this and would contact you to make that clear. Clearly I am caught between the 2 parties and need you both to clarify the conflicting legal position before I can provide a witness statement”
“What 3M have done is a clear attempt to interfere with our clients’ preparation of this litigation by using totally unjustified and unfounded suggestions of continuing interests of confidentiality coupled with threats to use the undoubted might of 3M against individuals who cannot possibly be expected to stand out against such intimidation. That is simply not acceptable.”
“(a) the document has been read to or by the court, or referred to, at a hearing which has been held in public; (b) the court gives permission; or (c) the party who disclosed the document and the person to whom the document belongs agree.”
“I am not satisfied that any advice or recommendation by OGP to the Consortium of the type alleged in the particulars of claim is either confidential or privileged as between the Consortium and FE and Techint. The actions of the Consortium in agreeing to disclose and inviting Techint to obtain such oral evidence from OGP as they wish is inconsistent with the claim to confidence and privilege now maintained. The Tribunal has already determined that documents of the description given in the particulars of claim are discloseable and are not privileged. Neither FE nor Techint has threatened to use any information they may obtain outside the proper confines of the arbitration.”
“… the court will grant a stay unless a claimant consents to relevant information being obtained from a treating doctor. There is no property in a witness, but there is a right of confidentiality between a patient and his treating doctor which the law will uphold. It is a right which it is for a patient to waive and he can only waive it voluntarily. The court will not order him to waive such a right. But in an appropriate case, the court can order that the claim be stayed until such time as he consents to waive his right of confidentiality.”
“Each case has to be decided on its own facts and the broad principle must be that the court has the task of deciding how justice can be achieved taking into account the rights and needs of the parties. The object to be achieved is that the applicant should have as full a degree of disclosure as will be consistent with adequate protection of the secret. In so doing, the court will be careful not to expose a party to any unnecessary risk of its trade secrets leaking to or being used by competitors. What is necessary or unnecessary will depend upon the nature of the secret, the position of the parties and the extent of the disclosure ordered. However, it would be exceptional to prevent a party from access to information which would play a substantial part in the case as such would mean that the party would be unable to hear a substantial part of the case, would be unable to understand the reasons for the advice given to him and, in some cases, the reasons for the judgment. Thus what disclosure is necessary entails not only practical matters arising in the conduct of a case but also the general position that a party should know the case he has to meet, should hear matters given in evidence and understand the reasons for the judgment.”
“We agree with you that some form of mutual confidentiality club would be sensible”
“However, it is clear that your clients are intent on using the issue of confidentiality to make sure that we and our clients are not able to investigate properly the relevant issues and the underlying facts and are not able to obtain the evidence which we might otherwise wish to adduce. That being the case, we are currently not minded to accede to your request that all of your clients’ disclosure should be treated as confidential …”
“(A) information on the Defendants’ investment strategy, and sales and profits projections for BacLite and for the Medical Division; (B) intelligence on the competitors of the Defendants’ Medical Division and their products; (C) proprietary research that the Defendants have conducted or commissioned into the markets for MRSA and other microbial detection products; (D) information on the resources and costs of the Defendants’ Medical Division, and specific financial and strategic information about Medical Division products other than BacLite. Many of these products are still actively sold by the Defendants; (E) specific information on the Fastman product, which the Defendants continue actively to develop; and (F) management-level documents in the possession of senior personnel within the Defendants concerning the finances of and the short-, medium- and long-term business strategies of the Defendants’ Medical Division.”
“The fact that a document discloses matter of commercial interest described as “sensitive” does not necessarily mean that it should be excluded from public inspection. Statements of this kind are too vague to give good grounds for consideration, and if a request is made for confidentiality of this type of material, a rather more exact indication should be given as to the reasons why the document ought not to be disclosed.”